Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Trading Update

6 Jan 2005 07:00

Torex Retail PLC06 January 2005 6 January 2005 TOREX RETAIL PLC TRADING UPDATE Torex Retail plc ("Torex Retail" or "the Group"), the UK's market leader inretail IT solutions, is pleased to announce that following the close of its yearend on 31 December 2004, it expects to report pre-tax profits ahead ofexpectations when it announces its preliminary results in February 2005. This reflects strong trading from all areas of the Group. The success of theGroup in the second half of 2004 is based upon sales of Group software productswith associated services, particularly with new contract wins for its marketleading EpoS product LUCAS. This has reinforced the changing business modelexperienced in the first half with increased software licence sales and lowerhardware revenues contributing to improved operating margins. In addition atight control on working capital has resulted in a strong cash inflow fromoperating activities. The integration of Alphameric Retail has commenced and initial findings areconsistent with pre-acquisition due diligence and the strategic rationale forthe transaction. In addition, new opportunities are being identified which isvery encouraging for 2005 and beyond. Rob Loosemore, Chairman of Torex Retail plc, commented: "I am delighted with the progress we have made in our first year as a publiccompany both in terms of financial performance and strategic development.Strong trading, particularly in the second half, together with the acquisitionof Alphameric's Retail Division provides a tremendous platform and momentum fororganic growth in 2005 and beyond. The pre-tax profits will be ahead ofexpectations which continues the long established tradition of the seniormanagement team, of not only doing what we say we will do but exceeding it." Enquiries: Torex Retail plc Citigate Dewe Rogerson Mark Pearman, Chief Executive Ginny Pulbrook / Seb Hoyle / Freida Moore Richard Thompson, Finance Director Telephone: +44 (0)20 7638 9571 Telephone: +44 (0)870 050 9900 Notes to Editors: Torex Retail, a leading European retail solutions business, floated on AIM inMarch 2004. The business is an independent supplier of electronic point of sale("EPOS") solutions and services and productivity tools to high street,convenience and petroleum retailers with an installed base of some 50,000 EPOSlicences across Europe. It has a broad base of blue-chip clients and employs700 staff in UK, Germany, Belgium, Holland and Eire. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jul 20138:45 amRNSTissue Regenix Key Appointment at USA Subsidiary
25th Jul 20134:59 pmRNSHolding(s) in Company
17th Jul 20137:00 amRNSAppointment of Non-Executive Director
10th Jul 20137:00 amRNSAppointment of Non-Executive Director
18th Jun 20137:00 amRNSTissue Regenix advances US commercialisation
14th Jun 201312:43 pmRNSResult of AGM
14th Jun 20137:00 amRNSPresentation of dCELL at heart valve event
28th May 20137:00 amRNSAppointment of Business Development Manager
14th May 20133:47 pmRNSAnnual Report and Notice of AGM
13th May 20137:00 amRNSPreliminary results for the year ended 31 Jan 2013
3rd May 20137:00 amRNSNotice of Results
2nd May 20137:00 amRNSResults of dCELL Dermis trial
29th Apr 20137:00 amRNSChange of Nominated Adviser and Broker
16th Apr 20137:00 amRNSApproval for start of clinical research trial
2nd Apr 20137:00 amRNSTissue Regenix makes appointment to US subsidiary
11th Mar 20137:00 amRNSDirector Change
15th Feb 20132:38 pmRNSHolding(s) in Company
14th Feb 20137:00 amRNSSuccessful safety study of dCELL® Meniscus
11th Feb 20132:57 pmRNSDirectorate Change
9th Jan 20137:15 amRNSHolding(s) in Company
30th Nov 201211:21 amRNSTissue Regenix board changes
26th Nov 20127:00 amRNSSets up US subsidiary
19th Nov 20127:00 amRNSAdds new patent global licence portfolio
4th Oct 20127:00 amRNSInterim data from clinical trial of dCELL® Dermis
4th Oct 20127:00 amRNSHalf Yearly Report
1st Oct 201210:57 amRNSTissue Regenix - senior development appointment
28th Sep 20123:30 pmRNSNotice of Results
7th Sep 20127:00 amRNSdCELL(R) vascular patch is safe and effective
2nd Aug 20122:31 pmRNSTissue Regenix makes appointment to Cardiac team
31st Jul 20123:02 pmRNSDirector/PDMR Shareholding
19th Jun 20122:39 pmRNSHolding(s) in Company
14th Jun 20127:00 amRNSResearch Update
11th Jun 201212:35 pmRNSResult of AGM
25th May 20127:00 amRNSExpands scope of development activities with NHSBT
10th May 20127:00 amRNSFinal Results
19th Apr 20121:49 pmRNSPoster shown at SAWC
16th Apr 20123:18 pmRNSNotice of Results
7th Feb 20124:00 pmRNSIssue of Equity and Total Voting Rights
11th Jan 201211:36 amRNSHolding(s) in Company
6th Jan 20125:05 pmRNSHolding(s) in Company
3rd Jan 20125:45 pmRNSHolding(s) in Company
3rd Jan 20125:43 pmRNSHolding(s) in Company
3rd Jan 20128:49 amRNSHolding(s) in Company
28th Dec 201112:00 pmRNSResult of General Meeting
8th Dec 201112:53 pmRNSIssue of Equity
25th Nov 20112:23 pmRNSUniversity Partner wins Queen's Anniversary Prize
4th Nov 20112:16 pmRNSHolding(s) in Company
14th Oct 20112:33 pmRNSHolding(s) in Company
10th Oct 20117:00 amRNSHalf Yearly Report
26th Jul 201111:04 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.